Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia
  2. Kashyap, Manoj Kumar; Karathia,Hiren; Kumar, Deepak; Vera Alvarez, Roberto; Forero-Forero, Jose Vicente; Moreno, Eider; Lujan, Juliana Velez; Amaya-Chanaga, Carlos Ivan; Vidal, Newton Medeiros; Yu, Zhe; Ghia, Emanuela M; Lengerke-Diaz, Paula A; Achinko, Daniel; Choi, Michael Y; Rassenti, Laura Z; Mariño-Ramírez, Leonardo; Mount, Stephen M; Hannenhalli, Sridhar; Kipps, Thomas J; Castro, Januario E
  3. Molecular Therapy. Nucleic acids. 2024, Jun 11; 35(2): 102202.
  1. 2.   Context-Dependent Function of Long Noncoding RNA PURPL in Transcriptome Regulation during p53 Activation
  2. Hartford, Corrine Corrina R; Shrestha, Roshan L; Pongor, Lorinc; Zhao,Yongmei; Chen, Xiongfong; Fromont,Caroline; Chaudhary, Ritu; Li, Xiao Ling; Pasterczyk, Katherine R; Kumar, Ravi; Muys, Bruna R; Tsitsipatis, Dimitrios; Chari,Raj; Gorospe, Myriam; Aladjem, Mirit I; Khan, Javed; Basrai, Munira A; Grammatikakis, Ioannis; Lal, Ashish
  3. Molecular and Cellular Biology. 2022, Nov 07; 42(12): e0028922.
  1. 3.   Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate
  2. Nagaya, Tadanobu; Gorka, Alexander P.; Nani, Roger R.; Okuyama, Shuhei; Ogata, Fusa; Maruoka, Yasuhiro; Choyke, Peter L.; Schnermann, Martin; Kobayashi, Hisataka
  3. MOLECULAR CANCER THERAPEUTICS. 2018, MAR; 17(3): 661-670.
  1. 4.   The "Topological Train Ride" of a Viral Long Non-Coding RNA
  2. Sztuba-Solinska, Joanna; Legrice, Stuart
  3. RNA Biology. 2018, Jan 02; 15(1): 13-16.
  1. 5.   Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates
  2. Di Mascio, M.; Paik, C. H.; Carrasquillo, J. A.; Maeng, J. S.; Jang, B. S.; Shin, I. S.; Srinivasula, S.; Byrum, R.; Neria, A.; Kopp, W.; Catalfamo, M.; Nishimura, Y.; Reimann, K.; Martin, M.; Lane, H. C.
  3. Blood. 2009 114(2): 328-337.
  1. 6.   Structure and Function of beta-1,4-Galactosyltransferase
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Current Drug Targets. 2008 9(4): 292-309.
  1. 7.   Rapid distribution of liposomal short-chain ceramide in vitro and in vivo
  2. Zolnik, B. S.; Stern, S. T.; Kaiser, J. M.; Heakal, Y.; Clogston, J. D.; Kester, M.; McNeil, S. E.
  3. Drug Metabolism and Disposition. 2008 36(8): 1709-1715.
  1. 8.   Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins
  2. Ostlund, C.; Sullivan, T.; Stewart, C. L.; Worman, H. J.
  3. Biochemistry. 2006, FEB 7; 45(5): 1374-1382.
  1. 9.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 10.   Qualitative assessment Of IC50 values of inhibitors of the neuronal nicotinic acetylcholine receptor using a single chromatographic experiment and multivariate cluster analysis
  2. Jozwiak, K.; Moaddel, R.; Yamaguchi, R.; Ravichandran, S.; Collins, J. R.; Wainer, I. W
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2005, MAY 5; 819(1): 169-174.
  1. 11.   Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappa B/p65 DNA binding
  2. Hu, J.; Colburn, N. H.
  3. Molecular Cancer Research. 2005, FEB; 3(2): 100-109.
  1. 12.   Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter
  2. Sugaya, M.; Watanabe, T.; Yang, A.; Starost, M. F.; Kobayashi, H.; Atkins, A. M.; Borris, D. L.; Hanan, E. A.; Schimel, D.; Bryant, M. A.; Roberts, N.; Skobe, M.; Staskus, K. A.; Kaldis, P.; Blauvelt, A.
  3. Blood. 2005 105(6): 2356-2363.
  1. 13.   5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking
  2. Catalano, A.; Caprari, P.; Soddu, S.; Procopio, A.; Romano, M.
  3. Faseb Journal. 2004, SEP; 18(12): Published online only.
  1. 14.   Facile photochemical synthesis of mixed siloxyacetal glycosides as potential pH-sensitized prodrugs for selective treatment of solid tumors
  2. Svarovsky, S. A.; Taraban, M. B.; Barchi, J. J.
  3. Organic & Biomolecular Chemistry. 2004 2(21): 3155-3161.
  1. 15.   Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location
  2. Maranchie, J. K.; Afonso, A.; Albert, P. S.; Kalyandrug, S.; Phillips, J. L.; Zhou, S.; Peterson, J.; Ghadimi, B. M.; Hurley, K.; Riss, J.; Vasselli, J. R.; Ried, T.; Zbar, B.; Choyke, P.; Walther, M. M.; Klausner, R. D.; Linehan, W. M.
  3. Human Mutation. 2004 23(1): 40-46.
  1. 16.   Interplay between plasmid partition and postsegregational killing systems
  2. Brendler, T.; Reaves, L.; Austin, S.
  3. Journal of Bacteriology. 2004 186(8): 2504-2507.
  1. 17.   Characterization and analysis of thermal denaturation of antibodies by size exclusion high-performance liquid chromatography with quadruple detection
  2. Hartmann, W. K.; Saptharishi, N.; Yang, X. Y.; Mitra, G.; Soman, G.
  3. Analytical Biochemistry. 2004 325(2): 227-239.
  1. 18.   A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types
  2. Lueders, K. K.; De Rosa, S. C.; Valentin, A.; Pavlakis, G. N.; Roederer, M.; Hamer, D. H.
  3. Aids Research and Human Retroviruses. 2004 20(2): 145-150.
  1. 19.   Phylogeography and subspecies assessment of vicunas in Chile and Bolivia utilizing mtDNA and microsatellite markers: implications for vicuna conservation and management
  2. Sarno, R. J.; Villalba, L.; Bonacic, C.; Gonzalez, B.; Zapata, B.; Mac Donald, D. W.; O'Brien, S. J.; Johnson, W. E.
  3. Conservation Genetics. 2004 5(1): 89-102.
  1. 20.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 21.   MICA and recovery from hepatitis C virus and hepatitis B virus infections
  2. Karacki, P. S.; Gao, X.; Thio, C. L.; Thomas, D. L.; Goedert, J. J.; Vlahov, D.; Kaslow, R.; Strathdee, S.; Hilgartner, M. W.; O'Brien, S. J.; Carrington, M.
  3. Genes and Immunity. 2004 5(4): 261-266.
  1. 22.   Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein
  2. Neumann, M.; Afonina, E.; Ceccherini-Silberstein, F.; Schlicht, S.; Erfle, V.; Pavlakis, G. N.; Brack-Werner, R.
  3. Journal of Cell Science. 2001 114(9): 1717-1729.
  1. 23.   Alternative splicing of the proadrenomedullin gene results in differential expression of gene products
  2. Martinez, A.; Hodge, D. L.; Garayoa, M.; Young, H. A.; Cuttitta, F.
  3. Journal of Molecular Endocrinology. 2001 27(1): 31-41.
  1. 24.   Transferrin Conjugates of Doxorubicin - Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy
  2. Kratz, F.; Beyer, U.; Roth, T.; Tarasova, N.; Collery, P.; Lechenault, F.; Cazabat, A.; Schumacher, P.; Unger, C.; Falken, U.
  3. Journal of Pharmaceutical Sciences. 1998 87(3): 338-346.
  1. 25.   The N-Terminal Domain of I-Kappa-B-Alpha Masks the Nuclear Localization Signal(S) of P50 and C-Rel Homodimers
  2. Latimer, M.; Ernst, M. K.; Dunn, L. L.; Drutskaya, M.; Rice, N. R.
  3. Molecular and Cellular Biology. 1998 18(5): 2640-2649.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel